Retraction Note: IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way

Affiliations

Xiang Zhang: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Dawei Wang: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Boke Liu: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Xingwei Jin: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Xianjin Wang: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Junwei Pan: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Weichao Tu: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Yuan Shao: Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Abstract

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-020-01657-0.

ISSN: 1756-9966 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jeccr.biomedcentral.com/